Depression and Echolalia
Summary:
Echolalia is found among people with Depression, especially for people who are male, 50-59 old.
The study analyzes which people have Echolalia with Depression. It is created by eHealthMe based on reports of 14 people who have Depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Depression?
Depression is found to be associated with 3,167 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.
What is Echolalia?
Echolalia (meaningless repetition of another person's spoken words -psychiatric disorder) is found to be associated with 33 drugs and 121 conditions by eHealthMe. Check the latest studies of Echolalia.
14 people who have Depression and Echolalia are studied.

Gender of people who have Depression and experienced Echolalia *:
- female: 23.08 %
- male: 76.92 %
Age of people who have Depression and experienced Echolalia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 25.0 %
- 20-29: 8.33 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 66.67 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Stress And Anxiety: 6 people, 42.86%
- Sleep Disorder: 6 people, 42.86%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 42.86%
- Suicide Attempt: 2 people, 14.29%
- Oropharyngeal Pain: 2 people, 14.29%
- Nasopharyngitis (inflammation of the nasopharynx): 2 people, 14.29%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 14.29%
- Insomnia (sleeplessness): 2 people, 14.29%
- Eating Disorder: 2 people, 14.29%
- Petit Mal Epilepsy (absence seizure): 1 person, 7.14%
Common drugs taken by these people *:
- Valium: 6 people, 42.86%
- Escitalopram: 3 people, 21.43%
- Melatonin: 2 people, 14.29%
- Chlorpheniramine Maleate: 2 people, 14.29%
- Depakote: 2 people, 14.29%
- Ibuprofen: 2 people, 14.29%
- Acetaminophen: 2 people, 14.29%
- Metformin: 2 people, 14.29%
- Miralax: 2 people, 14.29%
- Prozac: 2 people, 14.29%
Common symptoms for these people *:
- Dyskinesia (abnormality or impairment of voluntary movement): 6 people, 42.86%
- Stereotypy (excessive repetition or lack of variation in movements, ideas, or patterns of speech): 6 people, 42.86%
- Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 5 people, 35.71%
- Confusion: 4 people, 28.57%
- Catatonia (unresponsive to external stimuli): 4 people, 28.57%
- Depressed Mood: 3 people, 21.43%
- Head Injury: 3 people, 21.43%
- Drowsiness: 3 people, 21.43%
- Delirium (wild excitement): 3 people, 21.43%
- Confusional State: 3 people, 21.43%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Echolalia?
- Check whether Echolalia is associated with a drug or a conditionRelated publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Depression (652,144 reports)
- Echolalia (368 reports)
All the drugs that are associated with Echolalia:
- Echolalia (33 drugs)
All the conditions that are associated with Echolalia:
- Echolalia (121 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Echolalia and Depression, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Depakote Er and Meloxicam - 2 seconds ago
- Drug interactions of Augmentin and Diclofenac - 22 seconds ago
- Drug interactions of Ambrisentan and Vicodin - 26 seconds ago
- Drug interactions of Loratadine and Butorphanol Tartrate - 27 seconds ago
- Could Periogard cause Bone Density Decreased? - 27 seconds ago
- Drug interactions of Fluticasone Propionate and Efavirenz - 27 seconds ago
- Drug interactions of Ambrisentan and Pravastatin Sodium - 28 seconds ago
- Hypothyroidism and Hyperthyroidism - 32 seconds ago
- Drug interactions of Ambien and Neupro - 36 seconds ago
- Could Valproic Acid cause Neutrophil Count Abnormal? - 38 seconds ago